Paper · 34196366
The Eyes Absent proteins in development and in developmental disorders.
Soni UK and 2 others. Biochem Soc Trans, 2021. Cited by 16 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The Eyes Absent proteins in development and in developmental disorders. Papers, record 34196366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34196366
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Congenital Abnormalities | Major topic |
| Eye | Major topic |
| Gene Expression Regulation, Developmental | Major topic |
| Kidney | Major topic |
| Protein Tyrosine Phosphatases | Major topic |
| Trans-Activators | Major topic |
| Animals | |
| Genetic Predisposition to Disease | |
| Humans | |
| Mutation |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 HL152094 | NHLBI NIH HHS | United States | R01HL152094 | PubMed and NIH |
Source NIH RePORTER
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References90
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17,568,404 | A novel splice site mutation in EYA4 causes DFNA10 hearing loss. | Am J Med Genet A | 2007 | https://conductscience.org/library/papers/17568404 | PubMed |
| 2 | 23,251,383 | MAPK target sites of eyes absent are not required for eye development or survival in Drosophila. | PLoS One | 2012 | https://conductscience.org/library/papers/23251383 | PubMed |
| 3 | 18,678,597 | Eya1 gene dosage critically affects the development of sensory epithelia in the mammalian inner ear. | Hum Mol Genet | 2008 | https://conductscience.org/library/papers/18678597 | PubMed |
| 4 | 14,628,042 | Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis. | Nature | 2003 | https://conductscience.org/library/papers/14628042 | PubMed |
| 5 | 19,234,442 | Tyrosine dephosphorylation of H2AX modulates apoptosis and survival decisions. | Nature | 2009 | https://conductscience.org/library/papers/19234442 | PubMed |
| 6 | 20,418,914 | The Eyes Absent phosphatase-transactivator proteins promote proliferation, transformation, migration, and invasion of tumor cells. | Oncogene | 2010 | https://conductscience.org/library/papers/20418914 | PubMed |
| 7 | 33,649,104 | Targeting EYA3 in Ewing Sarcoma Retards Tumor Growth and Angiogenesis. | Mol Cancer Ther | 2021 | https://conductscience.org/library/papers/33649104 | PubMed |
| 8 | 16,797,546 | Branchio-oto-renal syndrome associated mutations in Eyes Absent 1 result in loss of phosphatase activity. | FEBS Lett | 2006 | https://conductscience.org/library/papers/16797546 | PubMed |
| 9 | 22,971,774 | The Eyes Absent proteins in development and disease. | Cell Mol Life Sci | 2013 | https://conductscience.org/library/papers/22971774 | PubMed |
| 10 | 33,242,174 | Expression of Eya1 in mouse taste buds. | Cell Tissue Res | 2021 | https://conductscience.org/library/papers/33242174 | PubMed |
1 to 10 of 90
See all 90 referencesCited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,539,001 | Genetic and Pharmacologic Targeting of Eya3 in Macrophages Drives Anti-Tumor Immunity in Triple-Negative Breast Cancer. | bioRxiv | 2026 | https://conductscience.org/library/papers/42539001 | PubMed |
| 42,304,399 | EYA1 regulates CIITA phosphorylation to promote EYA1-CIITA-Runx2 complex formation and extracellular matrix integrity in osteoarthritis. | Biol Direct | 2026 | https://conductscience.org/library/papers/42304399 | PubMed |
| 41,501,857 | DNA methylation analysis of NOTCH1 variants reveals the first episignature for non-syndromic congenital heart defects. | Genome Med | 2026 | https://conductscience.org/library/papers/41501857 | PubMed |
| 41,266,088 | Potent synthetic lethality between PLK1 and EYA family inhibitors in tumors of the central and peripheral nervous systems. | Genes Dev | 2026 | https://conductscience.org/library/papers/41266088 | PubMed |
| 41,257,561 | Genetic and epigenetic markers in the METTL21C gene associated with umbilical hernia in pigs. | BMC Genomics | 2025 | https://conductscience.org/library/papers/41257561 | PubMed |
| 39,819,101 | Familial Oculoauriculovertebral Spectrum: A Genomic Investigation of Autosomal Dominant Inheritance. | Cleft Palate Craniofac J | 2026 | https://conductscience.org/library/papers/39819101 | PubMed |
| 39,627,769 | SIX transcription factors are necessary for the activation of DUX4 expression in facioscapulohumeral muscular dystrophy. | Skelet Muscle | 2024 | https://conductscience.org/library/papers/39627769 | PubMed |
| 39,617,783 | Phosphorylation determines the glucose metabolism reprogramming and tumor-promoting activity of sine oculis homeobox 1. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/39617783 | PubMed |
| 39,381,636 | Incoherent collective cell chemotaxis underlies organ dysmorphia in a model of branchio-oto-renal syndrome. | MicroPubl Biol | 2024 | https://conductscience.org/library/papers/39381636 | PubMed |
| 39,316,168 | EYA-1 is required for genomic integrity independent of H2AX signalling in Caenorhabditis elegans. | Mol Biol Rep | 2024 | https://conductscience.org/library/papers/39316168 | PubMed |
1 to 10 of 14
See all 14 cited byGenes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| DACH1 | 1,602 | PubTator's text mining | https://conductscience.org/library/genes/1602 | NCBI Gene |
| EYA1 | 2,138 | PubTator's text mining | https://conductscience.org/library/genes/2138 | NCBI Gene |
| EYA2 | 2,139 | PubTator's text mining | https://conductscience.org/library/genes/2139 | NCBI Gene |
| LFNG | 3,955 | PubTator's text mining | https://conductscience.org/library/genes/3955 | NCBI Gene |
| NKX2-5 | 1,482 | PubTator's text mining | https://conductscience.org/library/genes/1482 | NCBI Gene |
| PAX3 | 5,077 | PubTator's text mining | https://conductscience.org/library/genes/5077 | NCBI Gene |
| PTPN22 | 26,191 | PubTator's text mining | https://conductscience.org/library/genes/26191 | NCBI Gene |
| SIX1 | 6,495 | PubTator's text mining | https://conductscience.org/library/genes/6495 | NCBI Gene |
| SIX5 | 147,912 | PubTator's text mining | https://conductscience.org/library/genes/147912 | NCBI Gene |
| SOX2 | 6,657 | PubTator's text mining | https://conductscience.org/library/genes/6657 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34196366
GET https://conductscience.org/api/papers/v1/34196366/references?page=2